# South America Microbiome Sequencing Services Market > South America Microbiome Sequencing Services Market Research Report: Size, Share, Trend Analysis By Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Others), By Applications (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, Others) andBy Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 2.74% - **2024:** $ 104.16 Million - **2025:** $ 107.02 Million - **2035:** $ 140.24 Million - **Key Players:** Illumina (US), Thermo Fisher Scientific (US), Zymo Research (US), Qiagen (DE), Genomatix (DE), Microbiome Insights (CA), Second Genome (US), CosmosID (US) **Report ID:** MRFR/HC/52151-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-america-microbiome-sequencing-services-market-53913 --- ## Market Summary ## **South America Microbiome Sequencing Services Market Overview****:** As per MRFR analysis, the South America Microbiome Sequencing Services Market Size was estimated at 151.41 (USD Million) in 2023.The South America Microbiome Sequencing Services Market Industry is expected to grow from 166.4(USD Million) in 2024 to 934.59 (USD Million) by 2035. The South America Microbiome Sequencing Services Market CAGR (growth rate) is expected to be around 16.986% during the forecast period (2025 - 2035). ### **Key South America Microbiome Sequencing Services Market Trends Highlighted** The South America Microbiome Sequencing Services Market is undergoing significant trends that are influencing its landscape. The growing recognition of the role microbiomes play in health and disease is a significant driver. Governments in South America are fostering the development and research of personalized medicine and biotechnology, which is fostering the study of the microbiome. This is particularly evident in the initiatives of health ministries that are designed to improve public health by leveraging scientific advancements.  Moreover, the local expertise in microbiome research is being enhanced by collaborations between universities and research institutions, which is fostering the development of sequencing services. In South America, opportunities are abundant, particularly as the agricultural sector adopts microbiome solutions to promote sustainable cultivation practices. The burgeoning interest in sustainable and organic agriculture presents an opportunity for microbiome sequencing services to contribute to the improvement of soil health and crop yield through microbial analysis.  Furthermore, the demand for microbiome comprehension in the development of alternative treatments presents substantial potential for growth as the region encounters an increase in antibiotic resistance. Recent developments suggest a transition to personalized healthcare solutions, which is bolstered by government investments in genomic research and technology infrastructure.The region's innovation is exemplified by the proliferation of enterprises that specialize in microbiome-related applications. Additionally, the introduction of sequencing technologies that are more reasonably priced is increasing the accessibility of advanced services to a broader audience. The demand for personalized nutrition services that are based on microbiome analysis is on the rise as consumers become more aware of the influence of diets on the microbiome. This trend suggests that microbiome research is becoming more integrated into daily health practices in South America. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **South America Microbiome Sequencing Services Market Drivers** ### **Growing Awareness of Gut Health and Its Impact on Disease** In South America, there has been a significant increase in the awareness of gut health and its relationship to various diseases. Research indicates that approximately 70% of the immune system resides in the gut, leading to a growing interest in microbiome studies. Major organizations like the Brazilian Society of Microbiology have been actively promoting educational programs and workshops, resulting in an increased interest in [microbiome sequencing services market](../../../reports/microbiome-sequencing-services-market-7532).  This heightened awareness can significantly drive market growth as healthcare professionals and researchers seek detailed analysis of gut microbiota to tailor treatments for conditions such as obesity, diabetes, and gastrointestinal disorders. According to a report by the Ministry of Health in Brazil, there has been a 15% rise in consultations regarding digestive health over the past three years, emphasizing the need for advanced microbiome sequencing services in the South America Microbiome Sequencing Services Market Industry. ### **Advancements in Sequencing Technologies** The South America Microbiome Sequencing Services Market is experiencing robust growth due to advancements in sequencing technologies. The introduction of next-generation sequencing has significantly reduced the costs and time associated with microbial genome sequencing, enabling more institutions to adopt these services. Notably, institutions like the National Laboratory of Scientific Computation in Brazil have been pioneers in developing these technologies, contributing to their accessibility in South America.The Brazilian government has initiated programs that fund genetic research, demonstrating a commitment to advancing microbiome studies. As sequencing becomes more cost-effective, experts predict an increasing adoption of microbiome sequencing services, ultimately driving the market growth. ### **Rising Incidence of Chronic Diseases** The rise in chronic diseases, particularly cardiovascular diseases and diabetes, represents a significant driver for the South America Microbiome Sequencing Services Market. According to the Pan American Health Organization, chronic diseases caused 80% of deaths in the region last year, which has prompted a focus on understanding the underlying factors, including gut microbiota. Major health organizations like the Argentine Society of Cardiology are emphasizing research that links gut microbiomes to cardiovascular health, leading to a surge in demand for microbiome sequencing.This focus on chronic disease prevention and management can catalyze the growth of the microbiome sequencing services market in South America. ## **South America Microbiome Sequencing Services Market Segment Insights****:** ### **Microbiome Sequencing Services Market Technology Insights** The Technology segment of the South America Microbiome Sequencing Services Market encompasses a diverse array of methodologies, each contributing uniquely to the advancement of microbiome research and analysis. Among these, Sequencing by Litigation (SBL) stands out due to its unique approach that leverages litigation-based analysis for microbiome exploration, driving deeper insights into complex microbial interactions and functionalities.  In contrast, Sequencing by Synthesis (SBS) is widely recognized for its accuracy and efficiency, making it a reliable choice for a variety of applications, including whole-genome sequencing and targeted analyses, thus becoming a preferred method for many research institutions in South America.Short Gun Sequencing, often favored for its ability to capture a comprehensive snapshot of the microbial community, allows researchers to explore untapped biodiversity within specific environments prevalent in the region, facilitating significant discoveries in ecological and clinical settings.  Targeted Gene Sequencing focuses on specific genes of interest, which is pertinent for studies aiming to unravel the genetic basis of microbial functions and their implications on human health, agriculture, and biotechnology, positioning it as a key player in the market.RNA Sequencing is also gaining traction as it provides insights into microbial gene expression, facilitating understanding of how microbes interact with their hosts, which is particularly crucial in a region rich in biodiversity.  The use of advanced technology in these areas is expected to enhance research outcomes, promote better disease understanding, and drive innovation in microbiome-related applications throughout South America. Collectively, these technologies are pivotal in shaping the industry landscape, as they facilitate significant advancements in microbiome research that cater specifically to the region's unique ecosystems and healthcare challenges.As each technology presents distinct advantages, their synergistic application supports the robust growth trajectory of the South America Microbiome Sequencing Services Market, offering vast opportunities for research and development. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ### **Microbiome Sequencing Services Market Application Insights** The Application segment of the South America Microbiome Sequencing Services Market plays a crucial role in understanding and addressing various health conditions. This market is primarily segmented into areas such as Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, and Others. Among these, Gastrointestinal Diseases are significant as they reflect the increasing prevalence of conditions like irritable bowel syndrome and inflammatory bowel disease, which are on the rise in the region. Infectious Diseases also dominate due to heightened concerns surrounding antibiotic resistance and the need for accurate diagnostics. The focus on Central Nervous System (CNS) Diseases is growing, particularly with rising awareness about disorders such as Alzheimer's and multiple sclerosis, where microbiome research may unveil novel therapeutic avenues. Oncology remains a critical area, with microbiome analysis offering insights that could enhance personalized cancer treatments. Other applications also contribute considerably to the market, driven by expanding opportunities in microbiome-related research and therapeutic developments. Overall, these applications highlight the transformative potential of microbiome sequencing technologies, aligning with the region's healthcare initiatives aimed at advancing precision medicine and improving patient outcomes. ### **Microbiome Sequencing Services Market Regional Insights** The South America Microbiome Sequencing Services Market is witnessing significant growth, driven by increasing investments in research, healthcare advancements, and rising awareness of microbiome-related studies. Within the region, Brazil holds a major position due to its robust research and development infrastructure and a growing population that holds an interest in personalized medicine and microbiome research. Mexico demonstrates considerable potential with its expanding biotechnology sector and governmental support for genomic research initiatives, making it a focal point for industry development. Argentina is gradually emerging as a key player as well, bolstered by its rising number of academic partnerships and collaborations focusing on microbiome studies. Meanwhile, the Rest of South America encompasses various countries that collectively contribute to the diversification and expansion of the microbiome services market, capitalizing on regional health concerns and fostering innovation. The overall growth is further fueled by increasing public and private funding aimed at enhancing scientific research, establishing a solid foundation for the South America Microbiome Sequencing Services Market as it prepares for future developments in genomics and personalized healthcare. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **South America Microbiome Sequencing Services Market Key Players and Competitive Insights****:** The South America Microbiome Sequencing Services Market is witnessing rapid growth, driven by an increasing understanding of the human microbiome's role in health and disease. This market includes a variety of players ranging from small biotech firms to established multinational companies that provide sequencing services tailored to the unique microbial communities found in different environments. Competitive insights into this market highlight the need for innovation and adaptation to local demands, as regulatory landscapes and customer needs vary significantly across South American countries. Companies operating in this space focus on advancing their technologies and expanding their service offerings to maintain a competitive edge.  As microbiome research gathers momentum in areas such as personalized medicine, agriculture, and environmental studies, these companies aim to leverage their expertise and resources, establishing partnerships and collaborations to enhance their market positions across the region.Zymo Research holds a significant presence in the South America Microbiome Sequencing Services Market, known for its commitment to providing high-quality microbiome analysis solutions. The company’s strengths lie in its innovative technologies and comprehensive product portfolio, which includes DNA extraction kits and microbial community profiling.  This focus on quality assures researchers and healthcare professionals of reliable results, making Zymo Research a preferred choice for microbiome studies in South America. The company's resilience in adapting to regional needs, along with a strong technical support team and educational resources, adds to its competitive advantage. Their ability to localize their offerings further strengthens their market position, giving them an edge over competitors in the increasingly sophisticated landscape of microbiome analysis.Element Biosciences is a key player in the South America Microbiome Sequencing Services Market, distinguished by its advanced DNA sequencing technologies and user-friendly solutions.  The company has developed key products that enable researchers to efficiently analyze microbiome samples, resulting in faster and more accurate insights. Their strong market presence in South America is bolstered by strategic partnerships with local research institutions, ensuring that researchers have access to cutting-edge sequencing services tailored to regional specifications. Element Biosciences emphasizes its strengths in cost-effective solutions that do not compromise on quality, enhancing its appeal to both academic and commercial sectors within the region. The company has also pursued mergers and acquisitions to expand its technology portfolio, which contributes to its ability to meet the evolving needs of the South American market, positioning it as a formidable competitor in the microbiome sequencing landscape. ### **Key Companies in the South America Microbiome Sequencing Services Market Include:** - Zymo Research - Element Biosciences - Bio-Rad Laboratories - Genscript - Genomatix Software - Qiagen - Thermo Fisher Scientific - Illumina - Agilent Technologies - Novogene - Oxford Nanopore Technologies - Merck KGaA - BGI Genomics - PacBio - Pierian Dx ## **South America Microbiome Sequencing Services Market Industry Developments** The South America Microbiome Sequencing Services Market has witnessed significant advancements recently, driven by growing investment in genomic research and rising health awareness among populations in the region. Companies such as Zymo Research, Illumina, and Thermo Fisher Scientific have been expanding their presence through various initiatives to enhance their service offerings. Notably, in June 2023, BGI Genomics acquired a local biotechnology firm to boost its portfolio in microbiome analysis. Additionally, Novogene has launched new projects focusing on agricultural microbiome analysis, aiming to support sustainable farming practices in South America.  The market is also influenced by the increasing demand for personalized medicine and the development of advanced sequencing technologies by firms like Qiagen and Agilent Technologies. In the past couple of years, from 2021 onwards, a noticeable growth in market valuation has been observed, prompting more collaborations among research institutions and companies to leverage microbiome data for health solutions. As public awareness of microbiome research continues to grow, local governments are providing funding to promote related scientific research, enhancing the market's potential in the region. ## **South America Microbiome Sequencing Services Market Segmentation Insights** ### **Microbiome Sequencing Services Market Technology****Outlook** - Sequencing by Litigation (SBL) - Sequencing by Synthesis (SBS) - Short Gun Sequencing - Targeted Gene Sequencing - RNA Sequencing - Others ### **Microbiome Sequencing Services Market Application****Outlook** - Gastrointestinal Diseases - Infectious Diseases - CNS Diseases - Oncology - Others **Microbiome Sequencing Services Market Regional****Outlook** - Brazil - Mexico - Argentina - Rest of South America ## Market Drivers ### Growing Awareness of Gut Health The increasing awareness of gut health among the South American population is driving the microbiome sequencing-services market. Consumers are becoming more informed about the role of gut microbiota in overall health, leading to a surge in demand for microbiome analysis. This trend is reflected in the rising number of health and wellness products that emphasize gut health, which has seen a growth rate of approximately 15% annually. As individuals seek personalized insights into their microbiomes, the microbiome sequencing-services market is likely to expand, with more companies offering tailored solutions to meet consumer needs. ### Expansion of Research Institutions The proliferation of research institutions dedicated to microbiome studies in South America is a significant driver for the microbiome sequencing-services market. These institutions are increasingly focusing on understanding the complex interactions between microbiomes and health, leading to a higher demand for sequencing services. In recent years, funding for microbiome research has increased, with government and private sectors investing over $100 million in various projects. This influx of resources is expected to enhance the capabilities of the microbiome sequencing-services market, fostering innovation and collaboration among researchers. ### Government Support for Biotechnology Government initiatives aimed at promoting biotechnology in South America are fostering growth in the microbiome sequencing-services market. Various countries are implementing policies to support research and development in the life sciences, including microbiome studies. This support is reflected in increased funding opportunities and tax incentives for biotech companies, which are likely to enhance the capabilities of the microbiome sequencing-services market. As governments prioritize health innovation, the market is expected to expand, with more resources allocated to microbiome research and its applications in healthcare. ### Rising Incidence of Chronic Diseases The escalating incidence of chronic diseases in South America is propelling the microbiome sequencing-services market. Conditions such as obesity, diabetes, and inflammatory bowel diseases are becoming more prevalent, prompting healthcare providers to explore microbiome analysis as a potential diagnostic tool. Studies indicate that the microbiome may play a crucial role in the development and management of these diseases, leading to a projected market growth of 20% in the coming years. Consequently, the microbiome sequencing-services market is likely to witness increased demand as healthcare professionals seek to leverage microbiome data for better patient outcomes. ### Technological Integration in Healthcare The integration of advanced technologies in healthcare is significantly influencing the microbiome sequencing-services market. Innovations such as artificial intelligence and machine learning are being utilized to analyze microbiome data more effectively, providing deeper insights into health and disease. This technological evolution is expected to enhance the accuracy and efficiency of microbiome sequencing services, attracting more healthcare providers to adopt these solutions. As a result, the microbiome sequencing-services market is poised for growth, with an anticipated increase in service offerings and improved patient care solutions. ## Future Outlook The [Microbiome Sequencing Services Market](https://www.marketresearchfuture.com/reports/microbiome-sequencing-services-market-7532) is projected to grow at a 2.74% CAGR from 2025 to 2035, driven by advancements in personalized medicine and increasing health awareness. **New opportunities:** - Development of subscription-based microbiome analysis services - Partnerships with healthcare providers for integrated solutions - Expansion into agricultural applications for soil microbiome analysis By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer demands and technological advancements. ## Segment Insights ### By Technology: Sequencing by Synthesis (Largest) vs. RNA Sequencing (Fastest-Growing) In the South America microbiome sequencing-services market, Sequencing by Synthesis (SBS) commands a significant share, establishing itself as the leading technology in the segment. It is followed closely by other methods such as Sequencing by Litigation (SBL) and Short Gun Sequencing, which collectively cater to a diverse range of research needs. Targeted Gene Sequencing and RNA Sequencing are also important players in the market, contributing to the steady growth of the segment. The growth trends in this segment are primarily driven by the increasing demand for advanced personalized medicine and tailored health solutions. Researchers are rapidly adopting RNA Sequencing due to its potential in identifying gene expressions and variations, positioning it as the fastest-growing technology. Moreover, innovation in sequencing technologies and a surge in funding for microbiome studies are fueling further advancements and market growth. Technology: Sequencing by Synthesis (Dominant) vs. RNA Sequencing (Emerging) Sequencing by Synthesis (SBS) is established as the dominant technology in the microbiome sequencing-services market, renowned for its efficiency and accuracy in generating high-quality sequences. This method supports large-scale projects and provides comprehensive insights into microbial genomics. In contrast, RNA Sequencing is an emerging technology that focuses on the transcriptome, allowing researchers to explore gene expression profiles in-depth. As the demand for precise and insightful genomic mapping increases, RNA Sequencing is gaining traction for its ability to reveal dynamic biological processes. The unique strengths of both technologies complement market needs, with SBS leading in volume while RNA Sequencing paves the way for new discoveries. ### By Application: Oncology (Largest) vs. Gastrointestinal Diseases (Fastest-Growing) The application segment distribution reflects a dynamic landscape in the microbiome sequencing-services market, with Oncology commanding the largest share due to the increasing focus on personalized medicine and targeted therapies. Gastrointestinal Diseases, while holding a smaller share, are on the rise as growing awareness regarding gut health and its correlation with overall wellness drives demand for microbiome analysis. Growth trends in the Application segment point towards significant advancements in technology and methodologies that facilitate more accurate and efficient sequencing. The market is witnessing rising investments from both public and private sectors aimed at fostering innovative solutions, particularly for CNS and infectious diseases. Furthermore, the increasing incidence of chronic conditions heightens the necessity for comprehensive microbiome research, thereby stimulating market growth. Oncology (Dominant) vs. Gastrointestinal Diseases (Emerging) Oncology stands as the dominant application in the microbiome sequencing-services market, benefiting from the integration of microbiome analysis in cancer treatment protocols and research. This segment's growth is propelled by an increasing body of evidence linking the microbiome to tumor development and response to therapies. Conversely, Gastrointestinal Diseases emerge as a significant focus area, driven by rising public interest in gut health and its implications for overall wellness. The correlation between gut microbiota and various diseases fosters a rapidly expanding market, as healthcare providers and researchers increasingly seek to understand and manipulate these microbial communities for better health outcomes. ## Regional Market Share Analysis ### Brazil : Strong Growth and Innovation Hub Brazil holds a commanding 45.0% market share in South America's microbiome sequencing-services sector, driven by increasing healthcare investments and a growing emphasis on personalized medicine. The demand for microbiome analysis is surging, fueled by rising awareness of gut health and its implications for overall well-being. Government initiatives, such as the National Health System's support for biotechnology, further bolster this growth. Additionally, Brazil's robust infrastructure and research facilities enhance its industrial capabilities, making it a key player in the region. ### Mexico : Diverse Applications and Growing Demand With a 25.0% market share, Mexico is rapidly establishing itself in the microbiome sequencing-services market. The country's growth is driven by increasing investments in healthcare and research, alongside a rising consumer interest in health and wellness. Regulatory frameworks are evolving to support biotechnology, while local universities and research institutions are fostering innovation. The demand for microbiome services is particularly strong in urban areas, where health awareness is higher and access to services is improving. ### Argentina : Focus on Health and Agriculture Argentina captures a 20.0% share of the microbiome sequencing-services market, with significant growth potential in both health and agricultural sectors. The increasing focus on sustainable agriculture and health diagnostics drives demand for microbiome analysis. Government policies promoting biotechnology research and development are crucial for market expansion. The competitive landscape includes local firms and international players, with Buenos Aires and Córdoba emerging as key markets for microbiome services, supported by academic institutions and research initiatives. ### Rest of South America : Varied Growth Across Sub-regions The Rest of South America holds a 14.16% market share in microbiome sequencing services, characterized by diverse market dynamics and varying levels of development. Countries like Chile and Colombia are witnessing growth due to increasing healthcare investments and awareness of microbiome health. However, regulatory challenges and infrastructure gaps remain significant hurdles. The competitive landscape is fragmented, with both local and international players vying for market share, particularly in urban centers where demand is rising. ## Competitive Benchmarking The microbiome sequencing-services market in South America is characterized by a dynamic competitive landscape, driven by increasing awareness of the microbiome's role in health and disease. Key players such as Illumina (US), Thermo Fisher Scientific (US), and Qiagen (DE) are at the forefront, leveraging their technological advancements and extensive product portfolios to capture market share. Illumina (US) focuses on innovation in sequencing technology, while Thermo Fisher Scientific (US) emphasizes comprehensive solutions that integrate sample preparation and analysis. Qiagen (DE) is strategically positioned through its robust bioinformatics capabilities, which enhance data interpretation and application in clinical settings. Collectively, these strategies foster a competitive environment that prioritizes technological advancement and comprehensive service offerings.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for dominance. However, the collective influence of major companies like Illumina (US) and Thermo Fisher Scientific (US) suggests a trend towards consolidation, as these firms seek to expand their geographic reach and service capabilities. In October Illumina (US) announced a partnership with a leading South American research institution to develop tailored microbiome sequencing solutions aimed at local health challenges. This collaboration is expected to enhance Illumina's market presence while addressing specific regional needs, thereby solidifying its competitive edge. The strategic importance of this partnership lies in its potential to foster innovation and drive localized research initiatives, which could lead to new product developments. In September Thermo Fisher Scientific (US) launched a new line of microbiome analysis kits designed for clinical laboratories in South America. This move not only expands their product offerings but also positions them as a key player in the clinical diagnostics space. The introduction of these kits is significant as it aligns with the growing demand for personalized medicine and targeted therapies, thereby enhancing the company's market relevance. In August Qiagen (DE) unveiled a new bioinformatics platform specifically tailored for microbiome data analysis, aimed at researchers in South America. This platform is designed to streamline data processing and interpretation, which is crucial for advancing microbiome research. The strategic importance of this development lies in its ability to provide researchers with the tools necessary to derive actionable insights from complex microbiome data, thereby fostering innovation in the field. As of November current trends in the microbiome sequencing-services market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) in data analysis. Strategic alliances among key players are shaping the competitive landscape, facilitating knowledge sharing and resource optimization. Looking ahead, it appears that competitive differentiation will increasingly hinge on innovation and technological advancements rather than price-based competition. Companies that prioritize supply chain reliability and invest in cutting-edge technologies are likely to emerge as leaders in this evolving market. ## Recent News & Developments The South America Microbiome Sequencing Services Market has witnessed significant advancements recently, driven by growing investment in genomic research and rising health awareness among populations in the region. Companies such as Zymo Research, Illumina, and Thermo Fisher Scientific have been expanding their presence through various initiatives to enhance their service offerings. Notably, in June 2023, BGI Genomics acquired a local biotechnology firm to boost its portfolio in microbiome analysis. Additionally, Novogene has launched new projects focusing on agricultural microbiome analysis, aiming to support sustainable farming practices in South America.  The market is also influenced by the increasing demand for personalized medicine and the development of advanced sequencing technologies by firms like Qiagen and Agilent Technologies. In the past couple of years, from 2021 onwards, a noticeable growth in market valuation has been observed, prompting more collaborations among research institutions and companies to leverage microbiome data for health solutions. As public awareness of microbiome research continues to grow, local governments are providing funding to promote related scientific research, enhancing the market's potential in the region. ## Report Scope | MARKET SIZE 2024 | 104.16(USD Million) | | --- | --- | | MARKET SIZE 2025 | 107.02(USD Million) | | MARKET SIZE 2035 | 140.24(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.74% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Illumina (US), Thermo Fisher Scientific (US), Zymo Research (US), Qiagen (DE), Genomatix (DE), Microbiome Insights (CA), Second Genome (US), CosmosID (US) | | Segments Covered | Technology, Application | | Key Market Opportunities | Growing demand for personalized health solutions drives innovation in the microbiome sequencing-services market. | | Key Market Dynamics | Rising demand for personalized medicine drives growth in microbiome sequencing-services across South America. | | Countries Covered | Brazil, Mexico, Argentina, Rest of South America | ## Frequently Asked Questions **Q: What is the current valuation of the microbiome sequencing-services market in South America?** A: The market valuation was $104.16 Million in 2024. **Q: What is the projected market valuation for 2035?** A: The projected valuation for 2035 is $140.24 Million. **Q: What is the expected CAGR for the market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period is 2.74%. **Q: Which companies are the key players in the microbiome sequencing-services market?** A: Key players include Illumina, Thermo Fisher Scientific, Zymo Research, Qiagen, Genomatix, Microbiome Insights, Second Genome, and CosmosID. **Q: What are the main technology segments in the microbiome sequencing-services market?** A: Main technology segments include Sequencing by Litigation, Sequencing by Synthesis, Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and Others. **Q: What was the market size for Sequencing by Synthesis in 2024?** A: The market size for Sequencing by Synthesis was $25.0 Million in 2024. **Q: What is the projected market size for Targeted Gene Sequencing by 2035?** A: The projected market size for Targeted Gene Sequencing is $25.0 Million by 2035. **Q: Which application segment had the highest valuation in 2024?** A: The Gastrointestinal Diseases application segment had the highest valuation at $30.0 Million in 2024. **Q: What is the expected growth for the Infectious Diseases application segment by 2035?** A: The expected growth for the Infectious Diseases application segment is projected to reach $30.0 Million by 2035. **Q: How does the market for CNS Diseases compare to other application segments?** A: The market for CNS Diseases was valued at $20.0 Million in 2024, indicating a moderate position compared to other segments. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-microbiome-sequencing-services-market-53913*